Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kaiser

Showing results (371-380 of 410) with videos related to

Pageof 41
Sort By:
Biorxiv : the Preprint Server for Biology|May 18, 2026
A Continuum of Atrial Peristalsis Initiates the Bicuspid to Quadricuspid Valve TransitionJing Wang, Aaron L Brown, Peng Zhao, et al.
Journal of the American Society for Mass Spectrometry|September 27, 2023
Development of a PNGase Rc Column for Online Deglycosylation of Complex Glycoproteins during HDX-MSThomas Lambert, Marius Gramlich, Luisa Stutzke, et al.
Life Science Alliance|May 30, 2024
Nanobodies as novel tools to monitor the mitochondrial fission factor Drp1Theresa Froehlich, Andreas Jenner, Claudia Cavarischia-Rega, et al.
Microbiological Research|December 19, 2020
Characterization of Lysinibacillus fusiformis strain S4C11: In vitro, in planta, and in silico analyses reveal a plant-beneficial microbeAlessandro Passera, Marzia Rossato, John S Oliver, et al.
Human Gene Therapy|October 4, 2019
Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System ManufacturingConstanze Radek, Ornellie Bernadin, Katharina Drechsel, et al.
Molecular Therapy. Methods & Clinical Development|March 26, 2021
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cellsNicole Cordes, Carolin Kolbe, Dominik Lock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Optimizing collection of adverse event data in cancer clinical trials supporting supplemental indicationsLee D Kaiser, Allen S Melemed, Alaknanda J Preston, et al.
EMBO Reports|December 20, 2021
Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concernTeresa R Wagner, Daniel Schnepf, Julius Beer, et al.
Frontiers in Immunology|October 30, 2024
Making the effect visible - OX40 targeting nanobodies for <i>in vivo</i> imaging of activated T cellsDesiree I Frecot, Simone Blaess, Teresa R Wagner, et al.
Cancers|October 13, 2021
Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription FactorsBettina Kotter, Fabian Engert, Winfried Krueger, et al.
Pageof 41

Showing results (371-380 of 410) with videos related to

Sort By:
Pageof 41
Biorxiv : the Preprint Server for Biology|May 18, 2026
A Continuum of Atrial Peristalsis Initiates the Bicuspid to Quadricuspid Valve TransitionJing Wang, Aaron L Brown, Peng Zhao, et al.
Journal of the American Society for Mass Spectrometry|September 27, 2023
Development of a PNGase Rc Column for Online Deglycosylation of Complex Glycoproteins during HDX-MSThomas Lambert, Marius Gramlich, Luisa Stutzke, et al.
Life Science Alliance|May 30, 2024
Nanobodies as novel tools to monitor the mitochondrial fission factor Drp1Theresa Froehlich, Andreas Jenner, Claudia Cavarischia-Rega, et al.
Microbiological Research|December 19, 2020
Characterization of Lysinibacillus fusiformis strain S4C11: In vitro, in planta, and in silico analyses reveal a plant-beneficial microbeAlessandro Passera, Marzia Rossato, John S Oliver, et al.
Human Gene Therapy|October 4, 2019
Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System ManufacturingConstanze Radek, Ornellie Bernadin, Katharina Drechsel, et al.
Molecular Therapy. Methods & Clinical Development|March 26, 2021
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cellsNicole Cordes, Carolin Kolbe, Dominik Lock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Optimizing collection of adverse event data in cancer clinical trials supporting supplemental indicationsLee D Kaiser, Allen S Melemed, Alaknanda J Preston, et al.
EMBO Reports|December 20, 2021
Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concernTeresa R Wagner, Daniel Schnepf, Julius Beer, et al.
Frontiers in Immunology|October 30, 2024
Making the effect visible - OX40 targeting nanobodies for <i>in vivo</i> imaging of activated T cellsDesiree I Frecot, Simone Blaess, Teresa R Wagner, et al.
Cancers|October 13, 2021
Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription FactorsBettina Kotter, Fabian Engert, Winfried Krueger, et al.
Pageof 41